Related Experiment Video
Updated: Jul 19, 2026

07:56
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Psychomotor performance and monoamine function in bipolar and unipolar affective disorders
A C Swann1, M M Katz, C L Bowden
1Department of Psychiatry and Behavioral Sciences, University of Texas-Houston Health Science Center, USA.
Biological Psychiatry
|July 1, 1999
Summary
Catecholamine function impacts psychomotor speed and visual tracking in affective disorders. Bipolar disorder patients showed impaired psychomotor function linked to catecholamines, unlike unipolar patients.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Affective disorders present with significant psychomotor abnormalities.
- These abnormalities may stem from altered catecholamine function affecting arousal and motivation.
Purpose of the Study:
- To investigate the relationship between psychomotor test performance and catecholamine system function.
- To differentiate these relationships in unipolar depression, bipolar disorder (manic, depressive, mixed episodes), and healthy controls.
Main Methods:
- Assessed psychomotor performance using tests of motor speed (reaction time, tapping speed) and visual tracking (trail making, dot placement).
- Measured catecholamine and metabolite concentrations in cerebrospinal fluid (CSF) and urine.
- Included medicine-free inpatients with unipolar depression or bipolar disorder, and age- and gender-matched healthy controls.
Main Results:
- Unipolar and bipolar depressed patients exhibited impairments in motor speed, dexterity, and visual tracking.
- Manic and mixed bipolar patients showed no significant psychomotor differences compared to controls.
- Tapping speed correlated with CSF 3-methoxy-4-hydroxyphenylglycol in controls and CSF homovanillic acid in bipolar depressed subjects.
- Increased catecholamine function was linked to slower psychomotor performance in bipolar disorder patients.
- Psychomotor function correlated with depression severity in bipolar but not unipolar patients.
Conclusions:
- Catecholamine systems are associated with heightened arousal and psychomotor impairment in bipolar disorder.
- The neurotransmitter relationships underlying psychomotor changes differ between unipolar and bipolar disorders.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

